Clinical Trials Logo
  1. Home
  2. Colorectal Cancer
  3. NCT05632744
  4. Details
NCT05632744 Clinical Trial

Evaluation of CG-100 Intraluminal Bypass Device

Colorectal Cancer Clinical Trial

Official title:
Evaluation of CG-100 Intraluminal Bypass Device

Clinical Trial Details — Status: Recruiting

Administrative data
NCT number NCT05632744
Other study ID # CLD-113
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 15, 2023
Est. completion date June 15, 2024

Study information
Verified date February 2024
Source Colospan Ltd.
Contact Shelly Sharon
Phone +972-50-2988415
Email shelly@colospan.com
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Evaluation of CG-100 Intraluminal Bypass device

Recruitment information / eligibility
Status Recruiting
Enrollment 10
Est. completion date June 15, 2024
Est. primary completion date June 15, 2024
Accepts healthy volunteers No
Gender All
Age group 22 Years to 75 Years
Eligibility Inclusion Criteria (pre-operative): 1. Willing to comply with protocol-specified follow-up evaluations 2. 22-75 (inclusive) years of age at screening 3. Diagnosed with colorectal cancer 4. Has been informed of the nature of the study, agrees to its provisions, and has provided written informed consent

Study Design

Related Conditions & MeSH terms

Intervention

Device:
• CG-100 Intraluminal Bypass Device
Subjects will be treated with the CG-100 Intraluminal Bypass Device

Locations
Country Name City State
Israel Soroka Medical Center Re?ovot

Sponsors (1)
Lead Sponsor Collaborator
Colospan Ltd.

Country where clinical trial is conducted

Israel, 

Outcome
Type Measure Description Time frame Safety issue
Primary Safety of the CG-100 Intraluminal Bypass Device Assessment of Serious Adverse Events 10 days
Secondary Safety of the CG-100 Intraluminal Bypass Device Assessment of Serious Adverse Events 4 weeks
See also
  Status Clinical Trial Phase
Recruiting NCT05400122 - Natural Killer (NK) Cells in Combination With Interleukin-2 (IL-2) and Transforming Growth Factor Beta (TGFbeta) Receptor I Inhibitor Vactosertib in Cancer Phase 1
Active, not recruiting NCT05551052 - CRC Detection Reliable Assessment With Blood
Completed NCT00098787 - Bevacizumab and Oxaliplatin Combined With Irinotecan or Leucovorin and Fluorouracil in Treating Patients With Metastatic or Recurrent Colorectal Cancer Phase 2
Recruiting NCT06037954 - A Study of Mental Health Care in People With Cancer N/A
Recruiting NCT05425940 - Study of XL092 + Atezolizumab vs Regorafenib in Subjects With Metastatic Colorectal Cancer Phase 3
Suspended NCT04595604 - Long Term Effect of Trimodal Prehabilitation Compared to ERAS in Colorectal Cancer Surgery. N/A
Completed NCT03414125 - Effect of Mailed Invites of Choice of Colonoscopy or FIT vs. Mailed FIT Alone on Colorectal Cancer Screening N/A
Completed NCT02963831 - A Study to Investigate ONCOS-102 in Combination With Durvalumab in Subjects With Advanced Peritoneal Malignancies Phase 1/Phase 2
Recruiting NCT05489211 - Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03) Phase 2
Terminated NCT01847599 - Educational Intervention to Adherence of Patients Treated by Capecitabine +/- Lapatinib N/A
Completed NCT05799976 - Text Message-Based Nudges Prior to Primary Care Visits to Increase Care Gap Closure N/A
Recruiting NCT03874026 - Study of Folfiri/Cetuximab in FcGammaRIIIa V/V Stage IV Colorectal Cancer Patients Phase 2
Active, not recruiting NCT03170960 - Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Phase 1/Phase 2
Completed NCT03181334 - The C-SPAN Coalition: Colorectal Cancer Screening and Patient Navigation N/A
Completed NCT03167125 - Participatory Research to Advance Colon Cancer Prevention N/A
Recruiting NCT04258137 - Circulating DNA to Improve Outcome of Oncology PatiEnt. A Randomized Study N/A
Recruiting NCT05568420 - A Study of the Possible Effects of Medication on Young Onset Colorectal Cancer (YOCRC)
Recruiting NCT02972541 - Neoadjuvant Chemotherapy Verse Surgery Alone After Stent Placement for Obstructive Colonic Cancer N/A
Completed NCT02876224 - Study of Cobimetinib in Combination With Atezolizumab and Bevacizumab in Participants With Gastrointestinal and Other Tumors Phase 1
Completed NCT01943500 - Collection of Blood Specimens for Circulating Tumor Cell Analysis N/A